Table 3.
Treatment outcomes by within 10 months after treatment initiation (n = 182,890)
| All N = 182890 |
Children (<10 years) N = 18259 |
Young Adolescents (10–14 years) N = 2032 |
Older Adolescents (15–19 years) N = 3931 |
Young Adults (20–24 years) N = 11686 |
Adults (25–49 years) N = 123363 |
Older Adults (≥50 years) N = 23619 |
|
|---|---|---|---|---|---|---|---|
| Treatment Successa | 152672 (83.48%) | 16727 (91.61%) | 1844 (90.75%) | 3399 (86.47%) | 9587 (82.04%) | 102192 (82.84%) | 18923 (80.12%) |
| All Outcomes | |||||||
| Completed | 94118 (51.46%) | 16298 (89.26%) | 1410 (69.39%) | 1639 (41.69%) | 4589 (39.27%) | 58757 (47.63%) | 11425 (48.37%) |
| Cured | 55625 (30.41%) | 244 (1.34%) | 390 (19.19%) | 1702 (43.30%) | 4844 (41.45%) | 41351 (33.52%) | 7094 (30.04%) |
| Died | 9909 (5.42%) | 209 (1.14%) | 52 (2.56%) | 109 (2.77%) | 389 (3.33%) | 6713 (5.44%) | 2437 (10.32%) |
| Loss to follow-up (LTFU) | 10001 (5.47%) | 631 (3.46%) | 60 (2.95%) | 224 (5.70%) | 890 (7.62%) | 7046 (5.71%) | 1150 (4.57%) |
| Treatment failed | 364 (0.20%) | 2 (0.01%) | 0 (0.00%) | 7 (0.18%) | 29 (0.25%) | 270 (0.22%) | 56 (0.24%) |
| Transferred out/not evaluated | 9835 (5.38%) | 681 (3.73%) | 75 (3.69%) | 191 (4.86%) | 782 (6.69%) | 7069 (5.73%) | 1037 (4.39%) |
| Still on treatment ≥10 months | 3038 (1.66%) | 194 (1.06%) | 45 (2.21%) | 59 (1.50%) | 163 (1.39%) | 2157 (1.57%) | 420 (1.78%) |
| Person-time in months | |||||||
| Full sample, median (IQR) | 6.1 (6.0–6.9) | 6.1 (6.0–6.4) | 6.2 (6.0–7.4) | 6.1 (6.0–6.8) | 6.1 (5.9–6.8) | 6.1 (5.9–7.1) | 6.1 (5.8–7.0) |
| Outcome sample, median (IQR) b | 6.1 (6.0–6.9) | 6.1 (6.0–6.4) | 6.2 (6.0–7.3) | 6.1 (6.0–6.8) | 6.1 (6.0–6.9) | 6.2 (6.0–7.1) | 6.1 (6.0–6.9) |
IQR interquartile range
aTreatment success is the sum of completed and cured. bPerson time calculated among those with a treatment outcomes assigned (i.e. excludes patients still on treatment and patients with no available outcome)